GT-055

• UNSPSC Description:

  GT-055 (LCB18-055) is a novel broad-spectrum β-lactamase inhibitor.

• Target Antigen:

  Beta-lactamase

• Type:

  Reference compound

• Related Pathways:

  Anti-infection

• Field of Research:

  Infection

• Assay Protocol:

  https://www.medchemexpress.com/gt-055.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(O)C(F)(F)F.O=C1[N@]2[C@@](C3=NOC(CN)(CN)C3)([H])CC[C@@H](N1OS(=O)(O)=O)C2

• Molecular Weight:

  463.39

• References & Citations:

  [1]Halasohoris SA, et al. In vitro and in vivo activity of GT-1, a novel siderophore cephalosporin, and GT-055, a broad-spectrum β-lactamase inhibitor, against biothreat and ESKAPE pathogens. J Antibiot (Tokyo). 2021 Dec;74(12):884-892.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  2842084-52-8